CATALOGO DEI PRODOTTI DELLA RICERCA

ZIPETO, Donato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.473
NA - Nord America 8.749
AS - Asia 8.421
SA - Sud America 896
AF - Africa 86
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 7
Totale 27.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.554
CN - Cina 4.253
RU - Federazione Russa 3.395
SG - Singapore 2.615
GB - Regno Unito 2.329
IT - Italia 877
BR - Brasile 750
FR - Francia 556
HK - Hong Kong 509
DE - Germania 497
SE - Svezia 483
IE - Irlanda 466
FI - Finlandia 412
VN - Vietnam 410
KR - Corea 241
UA - Ucraina 161
CA - Canada 117
ID - Indonesia 74
BE - Belgio 63
AR - Argentina 60
IN - India 59
MX - Messico 55
TR - Turchia 53
NL - Olanda 48
PL - Polonia 41
JP - Giappone 38
ZA - Sudafrica 35
AT - Austria 31
AU - Australia 30
BD - Bangladesh 30
EC - Ecuador 30
LT - Lituania 27
IQ - Iraq 24
ES - Italia 22
UZ - Uzbekistan 14
IR - Iran 12
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
PY - Paraguay 10
VE - Venezuela 10
CL - Cile 9
CO - Colombia 9
IL - Israele 9
MA - Marocco 9
TG - Togo 8
UY - Uruguay 8
JO - Giordania 7
NO - Norvegia 7
RO - Romania 7
SA - Arabia Saudita 7
EG - Egitto 6
KZ - Kazakistan 6
TN - Tunisia 6
BJ - Benin 5
BO - Bolivia 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
EU - Europa 5
KE - Kenya 5
NP - Nepal 5
OM - Oman 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CH - Svizzera 4
LB - Libano 4
LV - Lettonia 4
PA - Panama 4
PE - Perù 4
BG - Bulgaria 3
HU - Ungheria 3
SI - Slovenia 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CU - Cuba 1
Totale 27.646
Salva come PNG Salva come JPEG
Città #
Southend 2.051
Jacksonville 1.308
Singapore 1.273
Moscow 1.121
Chandler 1.066
Dallas 909
Ashburn 621
Hong Kong 502
Ann Arbor 481
Dublin 464
Woodbridge 456
Verona 449
Beijing 364
Houston 334
New York 214
Wilmington 193
Lawrence 185
Princeton 185
Nanjing 184
Los Angeles 160
Jinan 137
The Dalles 130
Ho Chi Minh City 121
Shenyang 115
Tianjin 96
Helsinki 95
Sindelfingen 90
Munich 88
Buffalo 83
Changsha 77
Dong Ket 74
Boardman 72
Hebei 72
São Paulo 72
Nanchang 65
Ningbo 62
Redondo Beach 62
Haikou 61
Seattle 61
Milan 60
Zhengzhou 60
Hangzhou 56
Brussels 55
Jakarta 54
Columbus 52
Hanoi 51
Redmond 45
Seoul 43
Taizhou 43
Jiaxing 41
Cambridge 40
Council Bluffs 38
Montreal 38
Santa Clara 38
Guangzhou 37
Lancaster 36
London 36
Taiyuan 34
Warsaw 33
Tokyo 31
Redwood City 30
Denver 28
Rio de Janeiro 28
Toronto 28
Atlanta 27
Turku 25
Brooklyn 24
Johannesburg 24
Norwalk 24
Oxford 24
San Francisco 24
Kent 23
Stockholm 23
Elora 22
Lanzhou 22
Vienna 22
Fuzhou 21
Bologna 20
Falls Church 19
Frankfurt am Main 19
Nuremberg 19
Lappeenranta 18
Mexico City 18
Poplar 18
Rome 18
Falkenstein 17
Buk-gu 16
Chicago 16
Orem 16
Shanghai 16
Amsterdam 15
Belo Horizonte 15
Phoenix 15
Trento 15
Da Nang 14
Chennai 13
Fairfield 13
Melbourne 13
San Jose 13
Vilnius 13
Totale 15.862
Salva come PNG Salva come JPEG
Nome #
CRISPR/Cas9 mediated knock-out of RUNX2 in melanoma cells 1.299
CRISPR/Cas9 genome editing in melanoma cells: new insight of RUNT domain 1.269
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 335
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 235
CRISPR/Cas9 as a tool for studying the interactions between viral and cellular proteins 235
Human T-cell leukemia virus HBZ and APH-2 antisense proteins interaction with host factors and their involvement in NF-Kb activation 212
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 210
Testing the performance of the imputation of MHC region in large datasets when using different reference panels 204
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 204
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 203
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 202
Gα15 in early onset of pancreatic ductal adenocarcinoma 202
Analysis of colorectal cancers for human cytomegalovirus presence 201
Analisi molecolare delle interazioni fra citomegalovirus umano e leucociti 200
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 198
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity 198
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 195
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 194
5. CRISPR/Cas9 for the Study of the Interactions between Viruses and Host 194
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 193
Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays 192
HTLV-1 and HTLV-2 Tax, HBZ and APH-2 interaction with host factors: their involvement in cellular pathways regulation. 191
HLA-C increases HIV-1 infectivity by interacting with the envelope glycoprotein gp120 190
Presence and role of HLA-C in HIV-1 infection 188
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 188
In silico structural prediction and in vitro functional validation to identify the ACOT8 regions involved in the interaction with HIV-1 Nef 188
HLA-C associates with Env and Increases HIV-1 infectivity 185
P-D9 Human Thioesterase 8 and HIV-1 Nef interaction 184
2. CRISPR/Cas9 to study virus-host interactions 184
A CRISPR/Cas9 based approach to study the implication of HTLV regulatory proteins in the NF-κB modulation. 183
CRISPR/Cas9 as a tool for the study of the interactions between viruses and host 182
A potential role of RUNX2- RUNT domain in modulating the expression of genes involved in bone metastases: an in vitro study with melanoma cells 182
Development of chimeric humanized monoclonal antibodies against HIV-1 181
Expression of a candidate vaccine for AIDS prevention in transgenic tobacco plants 180
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 180
Detection and typing of Human Cytomegalovirus DNA in colorectal cancer 178
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 178
HLA-C increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41. 178
The human T-cell leukemia virus -2 (HTLV-2) antisense protein APH-2 interacts with p65 and inhibits NF-ĸB Tax-2 activation. 177
HLA-C associates with Env and increases HIV-1 infectivity 176
Il ruolo di HLA-C nell'infezione da HIV-1 176
The Runt domain of RUNX2 induces the migration of melanoma cells to bone 175
Studiare la regione HLA negli esomi 174
Runx2 stimulates neoangiogenesis through the Runt domain in melanoma 172
HLA-C expression levels and binding stability to β2m are involved in HIV-1 infectivity 171
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 169
Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity 167
Induction of HIV-1 neutralizing antibodies by fusion complexes 165
Association Analysis Between HIV-1 Env and HLA-C Using Bimolecular Fluorescence Complementation 164
Association analysis between HIV-1 Env and HLAC using bimolecular fluorescence complementation 163
HTLV ANTISENSE PROTEINS ROLE IN THE NF-κB MODULATION. 163
New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration 162
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 161
Host-virus interactions: HTLV antisense regulatory proteins play a role in the dysregulation of NF-κB pathway 161
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 160
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 158
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 158
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 153
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 153
Dissection of HLA-C gene region to investigate its association with complex traits 153
Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first? 151
New vaccine strategies for chronic viral infections 151
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 150
Influenza - Prous Science Integrity 150
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 149
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 148
Production of a candidate HIV-1 vaccine in transgenic tobacco plants 148
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 148
Unsung hero Robert C. Gallo 147
Physical activity prevents cartilage degradation: a metabolomics study pinpoints the involvement of vitamin B6 147
HLA-C and HIV-1: a matter of stability 147
Vectors derived from antibodies for transferring substances into cells 146
Vectors derived from antibodies for transfecting substances into cells 145
HIV-1 Env glycoprotein and HLA-C associate and increase HIV-1 infectivity 145
NF-κB activation mediated by HTLV-1 transactivator Tax protein is impaired in TRAF3 knock-out cells. 144
Delayed progression to AIDS in HTLV-I/HIV-1 coinfected intravenous drug users 143
HTLV deregulation of the NF-κB pathway: an update on tax and antisense proteins role 143
HLA-C stability and AIDS progression 140
Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity" 139
TRAF3 involvement in the NF-κB pathway deregulation mediated by HTLV-1 Tax protein 137
Cell-based vaccination: rationale for the use of cells co-expressing HIV anv gp120 and HLA class I Cw4 molecules for the induction of neutralizing antibodies 135
Expression and purification of recombinant HTLV-II Tax protein in E.Coli and mammalian cells 133
HTLV-1 BASIC LEUCIN ZIPPER FACTOR AND ITS HOMOLOGOUS APH-2 IMPAIR NF-κB ACTIVATION MEDIATED BY THE VIRAL ONCOPROTEIN TAX. 133
Involvement of HLA-C binding stability to β2-microglobulin in HIV-1 infection 133
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 132
CRISPR/Cas system: an emerging technology in stem cell research 132
Gelsolin activity controls efficient early HIV-1 infection 130
TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins 130
A fast and reliable method for detecting SNP rs67384697 (Hsa-miR-148a binding site) by a single run of allele-specific real-time PCR 130
Single-chain antibody fragments for transferring substance 129
Quantificazione del DNA di citomegalovirus umano (HCMV) nei leucociti di pazienti immunocompromessi mediante polymerase chain reaction 128
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 127
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 127
HLA-C increases HIV-1 infectivity and is associated with gp120 125
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 125
ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19 124
Human cytomegalovirus viremia in HIV-1 seropositive patients at various clinical stages of infection 122
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma 122
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2 121
A simple method for human cytomegalovirus (HCMV) DNA quantitation in clinical samples 120
Totale 18.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.756
article - articoli 36.209
book - libri 3.855
conference - conferenze 43.288
curatela - curatele 0
other - altro 0
patent - brevetti 1.075
selected - selezionate 0
volume - volumi 1.329
Totale 171.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021897 0 0 0 0 0 202 75 135 140 16 197 132
2021/20221.498 155 338 16 77 47 48 48 99 54 67 146 403
2022/20233.232 253 312 304 571 288 755 27 196 363 40 75 48
2023/20243.664 66 145 153 180 189 2.278 114 96 19 73 201 150
2024/20254.121 268 264 140 623 174 87 297 210 659 283 272 844
2025/20267.838 811 617 971 1.922 2.918 599 0 0 0 0 0 0
Totale 27.860